SCHEMBL4028309

SCHEMBL4028309

COC(=O)c1nc(-c2sccc2N)n(C)c(=O)c1OC(C)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 5/20 0.34
HPGD P15428 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ERCC1 P07992 2/20 0.34
FEN1 P39748 2/20 0.34
ERCC4 Q92889 2/20 0.34
HSD17B10 Q99714 2/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRB2 P47870 1/20 0.34
GABRA4 P48169 1/20 0.34
GABRE P78334 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4028095 0.89 GABRP (0.32) ALDH1A1KDM4EHPGDSMN1; SMN2ERCC1
SCHEMBL4032112 0.86 ALDH1A1 (0.34) ALDH1A1KDM4EHPGDSMN1; SMN2ERCC1
SCHEMBL4028108 0.84 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2ERCC1FEN1ERCC4
SCHEMBL4030167 0.84 ERCC1 (0.46) ALDH1A1KDM4EHPGDSMN1; SMN2ERCC1
SCHEMBL4029058 0.75 ERCC1 (0.36) ALDH1A1KDM4EHPGDERCC1FEN1
SCHEMBL4031833 0.74 ELANE (0.31) ALDH1A1ERCC1FEN1ERCC4MAPT
SCHEMBL4026719 0.74 ALDH1A1 (0.34) ALDH1A1HPGDERCC1FEN1ERCC4
SCHEMBL6436946 0.73 FEN1 (0.62) ERCC1FEN1ERCC4
Hydrochloric Acid SCHEMBL4031283 0.72 FEN1 (0.60) ERCC1FEN1ERCC4
SCHEMBL4030445 0.72 ALDH1A1 (0.33) ALDH1A1ERCC1FEN1ERCC4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1470113-B1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2009-01-07 EP disclosed
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2005-06-16 US disclosed
EP-1470113-A1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2004-10-27 EP disclosed
WO-2003062211-A1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2003-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors POLR2A, POLR1E, POLR2E ALDH1A1 255/4885KDM4E 2458/4885HPGD 1570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.